Guardant Health Inc. Common Stock vs IQVIA Holdings Inc. Common Stock — how do they compare? Guardant Health Inc. Common Stock trades at $168.88 (market cap $22.22B), while IQVIA Holdings Inc. Common Stock trades at $261.38 (market cap $42.61B). The key difference: IQVIA Holdings Inc. Common Stock is the larger of the two by market cap, and IQVIA Holdings Inc. Common Stock is more actively traded (988,398 versus 1,589,453). Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and IQVIA Holdings Inc. Common Stock for 0 Days on average.
| GH | IQV | |
|---|---|---|
Market Cap | $22.22B | $42.61B |
Volume | 1,589,453 | 988,398 |
Sector | Health | Health |
52-Week High | $187.22 | $275.02 |
52-Week Low | $61.73 | $156.66 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $22.86B | $56.77B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →